Citi Re-Opens 90-Day Upside Catalyst Watch on Roivant Sciences (ROIV)
Tweet Send to a Friend
Citi analyst Samantha Semenkow reiterated a Buy rating and a $46.00 price target on Roivant Sciences (NASDAQ: ROIV), while opening ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




